Prediction of immunotherapy efficacy and immunomodulatory role of hypoxia in colorectal cancer

Immunotherapy has been used in the clinical treatment of colorectal cancer (CRC); however, most patients fail to achieve satisfactory survival benefits. Biomarkers with high specificity and sensitivity are being increasingly developed to predict the efficacy of CRC immunotherapy. In addition to DNA...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Zhuangzhuang, Bian, Chenbin, Wang, Huanhuan, Su, Jing, Meng, Lingbin, Xin, Ying, Jiang, Xin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Genomic Biomarkers in Cancer Immunotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679351/
https://www.ncbi.nlm.nih.gov/pubmed/36425871
http://dx.doi.org/10.1177/17588359221138383

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679351/
https://www.ncbi.nlm.nih.gov/pubmed/36425871
http://dx.doi.org/10.1177/17588359221138383

Ejemplares similares